Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 27 studies | 46% ± 18% | |
pericyte | 20 studies | 34% ± 17% | |
fibroblast | 19 studies | 39% ± 16% | |
macrophage | 17 studies | 39% ± 23% | |
astrocyte | 15 studies | 38% ± 17% | |
oligodendrocyte | 14 studies | 48% ± 17% | |
oligodendrocyte precursor cell | 14 studies | 63% ± 21% | |
endothelial cell of lymphatic vessel | 13 studies | 41% ± 23% | |
smooth muscle cell | 12 studies | 32% ± 13% | |
microglial cell | 12 studies | 46% ± 11% | |
adipocyte | 10 studies | 33% ± 9% | |
glutamatergic neuron | 9 studies | 53% ± 25% | |
type I pneumocyte | 8 studies | 52% ± 21% | |
GABAergic neuron | 8 studies | 41% ± 19% | |
ciliated cell | 8 studies | 33% ± 16% | |
myeloid cell | 7 studies | 41% ± 16% | |
neuron | 6 studies | 38% ± 23% | |
epithelial cell | 6 studies | 28% ± 10% | |
interneuron | 5 studies | 40% ± 16% | |
B cell | 5 studies | 22% ± 6% | |
capillary endothelial cell | 5 studies | 32% ± 9% | |
cardiac muscle cell | 5 studies | 53% ± 13% | |
vein endothelial cell | 5 studies | 39% ± 22% | |
monocyte | 5 studies | 26% ± 5% | |
type II pneumocyte | 5 studies | 32% ± 9% | |
granule cell | 4 studies | 23% ± 5% | |
dendritic cell | 4 studies | 29% ± 5% | |
mesothelial cell | 4 studies | 34% ± 10% | |
Mueller cell | 4 studies | 61% ± 15% | |
amacrine cell | 4 studies | 31% ± 10% | |
retina horizontal cell | 4 studies | 25% ± 10% | |
retinal cone cell | 4 studies | 28% ± 8% | |
retinal rod cell | 4 studies | 36% ± 14% | |
myofibroblast cell | 4 studies | 35% ± 17% | |
mast cell | 4 studies | 38% ± 13% | |
club cell | 4 studies | 31% ± 11% | |
endothelial cell of sinusoid | 3 studies | 37% ± 11% | |
endothelial cell of artery | 3 studies | 23% ± 3% | |
glycinergic amacrine cell | 3 studies | 26% ± 3% | |
retinal ganglion cell | 3 studies | 48% ± 9% | |
lymphocyte | 3 studies | 25% ± 8% | |
endothelial cell of vascular tree | 3 studies | 48% ± 15% | |
connective tissue cell | 3 studies | 30% ± 18% | |
alveolar macrophage | 3 studies | 29% ± 8% | |
respiratory goblet cell | 3 studies | 32% ± 11% | |
muscle cell | 3 studies | 29% ± 12% | |
brush cell | 3 studies | 33% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 4832.86 | 1429 / 1445 | 100% | 9.46 | 183 / 183 |
brain | 99% | 3360.45 | 2617 / 2642 | 100% | 16.36 | 702 / 705 |
skin | 100% | 7009.04 | 1808 / 1809 | 97% | 9.48 | 460 / 472 |
intestine | 100% | 4669.99 | 966 / 966 | 97% | 6.68 | 511 / 527 |
breast | 100% | 6155.80 | 459 / 459 | 96% | 8.13 | 1076 / 1118 |
lung | 100% | 10942.23 | 578 / 578 | 94% | 6.48 | 1085 / 1155 |
stomach | 96% | 2556.40 | 343 / 359 | 97% | 8.34 | 276 / 286 |
thymus | 100% | 4112.71 | 651 / 653 | 91% | 5.46 | 551 / 605 |
ovary | 100% | 3934.48 | 180 / 180 | 91% | 5.24 | 390 / 430 |
kidney | 97% | 2280.70 | 86 / 89 | 91% | 8.64 | 818 / 901 |
bladder | 100% | 4733.48 | 21 / 21 | 85% | 4.48 | 429 / 504 |
uterus | 100% | 4926.16 | 170 / 170 | 85% | 4.46 | 388 / 459 |
pancreas | 80% | 1350.95 | 261 / 328 | 98% | 7.37 | 174 / 178 |
adrenal gland | 100% | 2721.64 | 258 / 258 | 75% | 3.30 | 173 / 230 |
prostate | 98% | 3975.81 | 241 / 245 | 63% | 2.82 | 314 / 502 |
adipose | 100% | 7481.49 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6031.63 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 18219.02 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 5468.97 | 858 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 2108.49 | 778 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 5.65 | 72 / 80 |
liver | 38% | 535.46 | 87 / 226 | 46% | 1.76 | 187 / 406 |
tonsil | 0% | 0 | 0 / 0 | 76% | 3.65 | 34 / 45 |
lymph node | 0% | 0 | 0 / 0 | 69% | 3.23 | 20 / 29 |
peripheral blood | 32% | 925.31 | 294 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0048041 | Biological process | focal adhesion assembly |
GO_0016477 | Biological process | cell migration |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005925 | Cellular component | focal adhesion |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | PEAK1 |
Protein name | Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269) Pseudopodium enriched atypical kinase 1 |
Synonyms | KIAA2002 |
Description | FUNCTION: Probable catalytically inactive kinase. Scaffolding protein that regulates the cytoskeleton to control cell spreading and migration by modulating focal adhesion dynamics . Acts as a scaffold for mediating EGFR signaling . . |
Accessions | ENST00000312493.5 H3BUE6 ENST00000565820.5 Q9H792 ENST00000558305.5 H3BUZ5 ENST00000560626.6 ENST00000682557.1 H0YN99 ENST00000564328.5 |